Last reviewed · How we verify

NCT05206253

Effectiveness of Egg Versus Whey Protein Powder During Resistance Training

Completed NA Last updated 29 May 2024
What this trial tests

NA trial testing Whole egg powder in Muscle Atrophy in 115 participants. Completed in 31 August 2023.

Timeline
30 May 2022
Primary endpoint
31 August 2023
31 August 2023

Quick facts

Lead sponsorUniversity of Saskatchewan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeother
Enrollment115
Start date30 May 2022
Primary completion31 August 2023
Estimated completion31 August 2023
Sites2 locations across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Saskatchewan

Who can join

Adults 18 to 35, any sex, with Muscle Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Consumption of whole eggs has recently been shown to stimulate muscle protein synthesis to a greater degree than consumption of egg whites after a resistance training session. It is theorized that the egg yoke contains bio-active nutrients that enhance the protein provided by egg whites. The study will evaluate the effect of whole egg powder compared to whey protein powder and placebo over 12 weeks of resistance training in men and women who are participating in resistance training programs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Whole egg powder

Trials testing the same drug.

Other recruiting trials for Muscle Atrophy

Currently open trials in the same condition.

Other University of Saskatchewan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05206253.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing